©2024 Stanford Medicine
Choice of Modality of Follow up for Medication Abortion
Not Recruiting
Trial ID: NCT04056637
Purpose
This study will assess the impact of providing medication abortion-seeking clients a choice
for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last
menstrual period) at the study site for first trimester medication abortion will be invited
to participate. We hypothesize that providing clients with flexible follow-up options will
improve follow-up rates.
This study is not to assess efficacy or safety of follow-up methods--that has been well
established in practice and research. This is to assess choice of follow-up.
Official Title
Choice of Modality of Follow up for Medication Abortion
Stanford Investigator(s)
Paul D. Blumenthal, MD, MPH
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus
Eligibility
Inclusion Criteria:
- Eligible for medication abortion <63 days gestational age
- In general good health
- English or Spanish speaking competency
- Willing and able to sign consent forms
Exclusion Criteria:
- Clients less than 18 years of age.
- Any client not meeting the inclusion criteria listed above will be excluded from
participating in the trial.
Intervention(s):
other: Choice of follow-up option
device: Multi-level pregnancy test
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Research Manager, MPH
650-721-1562